| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |